IndraLab

Statements


9 1 | 1 31 30

sparser
"When PRAS40 is bound to mTOR, mTOR activity is reduced; in contrast, when mTOR detaches from PRAS40, mTOR is active ( xref )."

reach
"Increased p-raptor (S792) or PRAS40 binding to mTOR was inhibited by Compound C (XREF_FIG and XREF_FIG; XREF_SUPPLEMENTARY and XREF_SUPPLEMENTARY), suggesting that AMPK mediates iron chelation increased p-raptor and PRAS40 binding to mTOR."

reach
"In human cells, PRAS40 binds to mTOR in an insulin dependent manner and may act as a negative regulator of TORC1 in the absence of insulin."

sparser
"To verify whether AMPK mediates increased p-raptor (S792) or PRAS40 binding to mTOR, IP against mTOR was performed after cells were treated with CPX or Dp44mT, with/without Compound C pretreatment."

sparser
"In the presence of EtOH, there was an increased interaction between PRAS40 and mTOR."

reach
"In the presence of EtOH, there was an increased interaction between PRAS40 and mTOR."

sparser
"Increased p-raptor (S792) or PRAS40 binding to mTOR was inhibited by Compound C (Figs. xref and xref ), suggesting that AMPK mediates iron chelation-increased p-raptor/PRAS40 binding to mTOR."

No evidence text available

sparser
"Genetic investigation of the factors associated with PRAS40 induction during mTOR inhibition identified amplification of EGFR, MDM2, and PDGFRA as more common in the non-responder subgroup, a finding not predicted from preclinical work."

trips
"PRAS40 binds the mTOR kinase domain and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition."